Estimated read time: Less than a minute
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
NEW YORK (AP) - Shares of Acceleron Pharma are surging after the drug developer said its initial public offering priced at the high end of estimates.
Acceleron's IPO of 5.6 million shares priced at $15 per share, bringing it $83.7 million before expenses and underwriting discounts. The Cambridge, Mass., had expected to sell 4.7 million shares for $13 to $15 each.
The underwriters of the IPO will have the option to buy another 837,000 shares.
Acceleron Pharma Inc. shares advanced $5.10, or 34 percent, to $20.10 while the broader markets were down.
The stock is listed on the Nasdaq Global Market under the symbol "XLRN."
Separately, Celgene Corp. will buy 666,667 shares for $15 each, giving Acceleron another $10 million. The companies are studying two drugs together.
(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)